Overall rank by patents
#33,225
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 2 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
Skintech holds 8 US patents across 2 technology areas, rank #33,225 of 50,000 tracked assignees.
Skintech LIFE Science Limited has been granted 8 US utility patents between 2015 and 2024, placing Skintech LIFE Science Limited at rank #33,225 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.5 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Skintech LIFE Science Limited is one of the more focused assignees in the PatentsView dataset. By volume, Skintech sits between SINO Medical Sciences Technology Inc. (8 patents, rank #33,221) and Slcket, Inc. (8 patents, rank #33,229) - the closest US assignees by grant volume. The composite Innovation Score of 34.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 4 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Skintech LIFE Science Limited's 19.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Skintech LIFE Science Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SINO MEDICAL SCIENCES TECHNOLOGY INC.
8 patents
SITRUS TECHNOLOGY CORPORATION
8 patents
SKC HI-TECH & MARKETING CO., LTD.
8 patents
SKG INC.
8 patents
SKYBOX SECURITY, INC.
8 patents
SKYGRID, LLC
8 patents
SKYRE INC.
8 patents
SLCKET, Inc.
8 patents
SKINTECH LIFE SCIENCE LIMITED
8 patents
What this shows Skintech holds 8 patents at rank #33,225, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #33,225 in granted patent volume.
Other assignees with the most granted patents in Skintech's primary technology class.
Skintech's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 53% higher than 47% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 12.5% |
| 2016 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
| 2019 | 1 | 12.5% |
| 2021 | 1 | 12.5% |
| 2022 | 2 | 25.0% |
| 2024 | 1 | 12.5% |
Top 2 of 2 technology areas
Overall rank by patents
#33,225
Across all tracked assignees
34.3 out of 100
How to use this portfolio
Skintech's 8 grants land it in the top 53% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.